Rebirth

I'm Interested!

Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy (REBIRTH) for Peripartum Cardiomyopathy

Sex at Birth: Female
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase IV
Conditions Being Studied: Cardiomyopathy

Study Purpose

The purpose of the study is to test the use of a drug called bromocriptine for women who have a condition called 'Peripartum cardiomyopathy' or PPCM. PPCM means you have a weak heart after giving birth. The study will look at how the heart muscle improves in women taking bromocriptine compared to a group of women given a placebo or inactive pill

Who Can Participate

Age: 18 and older

Principal Investigator
Chantal ElAmm MD

Department/Division
Heart Failure (Heart and Vascular)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: SITE00001796
StudyID: 2023-01167
ClinicalTrials.gov: NCT05180773

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422